Literature DB >> 24251430

Admission rates and costs associated with emergency presentation of urolithiasis: analysis of the Nationwide Emergency Department Sample 2006-2009.

Samuel H Eaton1, John Cashy, Jeffrey A Pearl, Daniel M Stein, Kent Perry, Robert B Nadler.   

Abstract

BACKGROUND AND
PURPOSE: We sought to examine a large nationwide (United States) sample of emergency department (ED) visits to determine data related to utilization and costs of care for urolithiasis in this setting.
METHODS: Nationwide Emergency Department Sample was analyzed from 2006 to 2009. All patients presenting to the ED with a diagnosis of upper tract urolithiasis were analyzed. Admission rates and total cost were compared by region, hospital type, and payer type. Numbers are weighted estimates that are designed to approximate the total national rate.
RESULTS: An average of 1.2 million patients per year were identified with the diagnosis of urolithiasis out of 120 million visits to the ED annually. Overall average rate of admission was 19.21%. Admission rates were highest in the Northeast (24.88%), among teaching hospitals (22.27%), and among Medicare patients (42.04%). The lowest admission rates were noted for self-pay patients (9.76%) and nonmetropolitan hospitals (13.49%). The smallest increases in costs over time were noted in the Northeast. Total costs were least in nonmetropolitan hospitals; however, more patients were transferred to other hospitals. When assessing hospital ownership status, private for-profit hospitals had similar admission rates compared with private not-for-profit hospitals (16.6% vs 15.9%); however, costs were 64% and 48% higher for ED and inpatient admission costs, respectively.
CONCLUSIONS: Presentation of urolithiasis to the ED is common, and is associated with significant costs to the medical system, which are increasing over time. Costs and rates of admission differ by region, payer type, and hospital type, which may allow us to identify the causes for cost discrepancies and areas to improve efficiency of care delivery.

Entities:  

Mesh:

Year:  2013        PMID: 24251430      PMCID: PMC3869432          DOI: 10.1089/end.2013.0205

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  5 in total

Review 1.  Clinical practice. Acute renal colic from ureteral calculus.

Authors:  Joel M H Teichman
Journal:  N Engl J Med       Date:  2004-02-12       Impact factor: 91.245

2.  Urologic diseases in America project: urolithiasis.

Authors:  Margaret S Pearle; Elizabeth A Calhoun; Gary C Curhan
Journal:  J Urol       Date:  2005-03       Impact factor: 7.450

3.  Validity of administrative coding in identifying patients with upper urinary tract calculi.

Authors:  Michelle J Semins; Bruce J Trock; Brian R Matlaga
Journal:  J Urol       Date:  2010-05-15       Impact factor: 7.450

Review 4.  Urolithiasis in the emergency department.

Authors:  Autumn Graham; Samuel Luber; Allan B Wolfson
Journal:  Emerg Med Clin North Am       Date:  2011-08       Impact factor: 2.264

5.  Prevalence of kidney stones in the United States.

Authors:  Charles D Scales; Alexandria C Smith; Janet M Hanley; Christopher S Saigal
Journal:  Eur Urol       Date:  2012-03-31       Impact factor: 20.096

  5 in total
  12 in total

1.  CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update.

Authors:  Marie Dion; Ghada Ankawi; Ben Chew; Ryan Paterson; Nabil Sultan; Patti Hoddinott; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2016-11-10       Impact factor: 1.862

2.  Simultaneous vs staged treatment of urolithiasis in patients undergoing radical prostatectomy.

Authors:  Boyd R Viers; Matthew K Tollefson; David E Patterson; Matthew T Gettman; Amy E Krambeck
Journal:  World J Clin Cases       Date:  2014-11-16       Impact factor: 1.337

3.  The economics of stone disease.

Authors:  Noah E Canvasser; Peter Alken; Michael Lipkin; Stephen Y Nakada; Hiren S Sodha; Abdulkadir Tepeler; Yair Lotan
Journal:  World J Urol       Date:  2017-01-20       Impact factor: 4.226

4.  Dual energy can accurately differentiate uric acid-containing urinary calculi from calcium stones.

Authors:  A Spek; F Strittmatter; A Graser; P Kufer; C Stief; M Staehler
Journal:  World J Urol       Date:  2016-01-09       Impact factor: 4.226

5.  Lunar cycle, seasonal variation, and prevalence of emergency urological presentations: correlation or coincidence?-A preliminary report.

Authors:  Tosin S Akinpelu; Abdullah E Laher; Andrew Chen; Ahmed Adam
Journal:  Curr Urol       Date:  2021-03-29

6.  A Comparison of Urolithiasis in the Presence and Absence of Microscopic Hematuria in the Emergency Department.

Authors:  Jason M Mefford; Robert M Tungate; Leila Amini; Dongjin Suh; Craig L Anderson; Scott E Rudkin; Megan Boysen-Osborn
Journal:  West J Emerg Med       Date:  2017-05-15

Review 7.  Organotin Compounds Toxicity: Focus on Kidney.

Authors:  Carolina Monteiro de Lemos Barbosa; Fernanda Magalhães Ferrão; Jones B Graceli
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-22       Impact factor: 5.555

8.  Systemic inflammatory response syndrome in patients with acute obstructive upper tract urinary stone: a risk factor for urgent renal drainage and revisit to the emergency department.

Authors:  Spencer Larkin; Jeremy Johnson; Trisha Venkatesh; Joel Vetter; Ramakrishna Venkatesh
Journal:  BMC Urol       Date:  2020-06-29       Impact factor: 2.264

Review 9.  What are the clinical effects of the different emergency department imaging options for suspected renal colic? A scoping review.

Authors:  Erik Doty; Stephen DiGiacomo; Bridget Gunn; Lauren Westafer; Elizabeth Schoenfeld
Journal:  J Am Coll Emerg Physicians Open       Date:  2021-06-16

10.  Procalcitonin determined at emergency department as na early indicator of progression to septic shock in patient with sepsis associated with ureteral calculi.

Authors:  Young Hwii Ko; Yoon Seob Ji; Sin-Youl Park; Su Jin Kim; Phil Hyun Song
Journal:  Int Braz J Urol       Date:  2016 Mar-Apr       Impact factor: 1.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.